aeonian biotech limited
aeonian biotech limited Company Information
Company Number
11085027
Next Accounts
Dec 2024
Industry
Research and experimental development on biotechnology
Directors
Shareholders
jan voskuil
Group Structure
View All
Contact
Registered Address
5 the chambers, vineyard, abingdon, OX14 3PX
Website
-aeonian biotech limited Estimated Valuation
Pomanda estimates the enterprise value of AEONIAN BIOTECH LIMITED at £12.9k based on a Turnover of £12.1k and 1.06x industry multiple (adjusted for size and gross margin).
aeonian biotech limited Estimated Valuation
Pomanda estimates the enterprise value of AEONIAN BIOTECH LIMITED at £0 based on an EBITDA of £-1.8k and a 3.77x industry multiple (adjusted for size and gross margin).
aeonian biotech limited Estimated Valuation
Pomanda estimates the enterprise value of AEONIAN BIOTECH LIMITED at £0 based on Net Assets of £-3.3k and 1.89x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Aeonian Biotech Limited Overview
Aeonian Biotech Limited is a dissolved company that was located in abingdon, OX14 3PX with a Companies House number of 11085027. It operated in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in November 2017, it's largest shareholder was jan voskuil with a 100% stake. The last turnover for Aeonian Biotech Limited was estimated at £12.1k.
Upgrade for unlimited company reports & a free credit check
Aeonian Biotech Limited Health Check
Pomanda's financial health check has awarded Aeonian Biotech Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs
1 Strong
3 Regular
6 Weak
Size
annual sales of £12.1k, make it smaller than the average company (£2m)
- Aeonian Biotech Limited
£2m - Industry AVG
Growth
3 year (CAGR) sales growth of 10%, show it is growing at a similar rate (11.6%)
- Aeonian Biotech Limited
11.6% - Industry AVG
Production
with a gross margin of 25.4%, this company has a higher cost of product (49.7%)
- Aeonian Biotech Limited
49.7% - Industry AVG
Profitability
an operating margin of -15% make it as profitable than the average company (-13.8%)
- Aeonian Biotech Limited
-13.8% - Industry AVG
Employees
with 1 employees, this is below the industry average (38)
- Aeonian Biotech Limited
38 - Industry AVG
Pay Structure
on an average salary of £71.3k, the company has an equivalent pay structure (£71.3k)
- Aeonian Biotech Limited
£71.3k - Industry AVG
Efficiency
resulting in sales per employee of £12.1k, this is less efficient (£117.3k)
- Aeonian Biotech Limited
£117.3k - Industry AVG
Debtor Days
it gets paid by customers after 129 days, this is later than average (60 days)
- Aeonian Biotech Limited
60 days - Industry AVG
Creditor Days
its suppliers are paid after 288 days, this is slower than average (73 days)
- Aeonian Biotech Limited
73 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Aeonian Biotech Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Aeonian Biotech Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 172.7%, this is a higher level of debt than the average (56.8%)
172.7% - Aeonian Biotech Limited
56.8% - Industry AVG
AEONIAN BIOTECH LIMITED financials
Aeonian Biotech Limited's latest turnover from November 2021 is estimated at £12.1 thousand and the company has net assets of -£3.3 thousand. According to their latest financial statements, we estimate that Aeonian Biotech Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | |
|---|---|---|---|---|
| Turnover | ||||
| Other Income Or Grants | ||||
| Cost Of Sales | ||||
| Gross Profit | ||||
| Admin Expenses | ||||
| Operating Profit | ||||
| Interest Payable | ||||
| Interest Receivable | ||||
| Pre-Tax Profit | ||||
| Tax | ||||
| Profit After Tax | ||||
| Dividends Paid | ||||
| Retained Profit | ||||
| Employee Costs | ||||
| Number Of Employees | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | |
|---|---|---|---|---|
| Tangible Assets | 175 | 493 | 811 | 430 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 175 | 493 | 811 | 430 |
| Stock & work in progress | 0 | 0 | 0 | 0 |
| Trade Debtors | 4,306 | 6,105 | 2,304 | 2,690 |
| Group Debtors | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 54 | 271 | 0 |
| Cash | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 488 |
| total current assets | 4,306 | 6,159 | 2,575 | 3,178 |
| total assets | 4,481 | 6,652 | 3,386 | 3,608 |
| Bank overdraft | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 |
| Trade Creditors | 7,139 | 7,491 | 5,894 | 3,509 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 |
| total current liabilities | 7,139 | 7,491 | 5,894 | 3,509 |
| loans | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 600 | 600 | 600 | 600 |
| other liabilities | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 |
| total long term liabilities | 600 | 600 | 600 | 600 |
| total liabilities | 7,739 | 8,091 | 6,494 | 4,109 |
| net assets | -3,258 | -1,439 | -3,108 | -501 |
| total shareholders funds | -3,258 | -1,439 | -3,108 | -501 |
| Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | ||||
| Depreciation | ||||
| Amortisation | ||||
| Tax | ||||
| Stock | 0 | 0 | 0 | 0 |
| Debtors | -1,853 | 3,584 | -115 | 2,690 |
| Creditors | -352 | 1,597 | 2,385 | 3,509 |
| Accruals and Deferred Income | 0 | 0 | 0 | 600 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 |
| share issue | ||||
| interest | ||||
| cash flow from financing | ||||
| cash and cash equivalents | ||||
| cash | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 |
aeonian biotech limited Credit Report and Business Information
Aeonian Biotech Limited Competitor Analysis
Perform a competitor analysis for aeonian biotech limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other undefined companies, companies in OX14 area or any other competitors across 12 key performance metrics.
aeonian biotech limited Ownership
AEONIAN BIOTECH LIMITED group structure
Aeonian Biotech Limited has no subsidiary companies.
Ultimate parent company
AEONIAN BIOTECH LIMITED
11085027
aeonian biotech limited directors
Aeonian Biotech Limited currently has 1 director, Dr Jan Voskuil serving since Nov 2017.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Jan Voskuil | England | 65 years | Nov 2017 | - | Director |
P&L
November 2021turnover
12.1k
-33%
operating profit
-1.8k
0%
gross margin
25.5%
-27.68%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2021net assets
-3.3k
+1.26%
total assets
4.5k
-0.33%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
aeonian biotech limited company details
company number
11085027
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
November 2017
age
7
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
November 2021
previous names
N/A
accountant
-
auditor
-
address
5 the chambers, vineyard, abingdon, OX14 3PX
Bank
-
Legal Advisor
-
aeonian biotech limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to aeonian biotech limited.
aeonian biotech limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AEONIAN BIOTECH LIMITED. This can take several minutes, an email will notify you when this has completed.
aeonian biotech limited Companies House Filings - See Documents
| date | description | view/download |
|---|
